Cargando…

Extent of Surgery Does Not Influence 30-Day Mortality in Surgery for Metastatic Bone Disease: An Observational Study of a Historical Cohort

Estimating patient survival has hitherto been the main focus when treating metastatic bone disease (MBD) in the appendicular skeleton. This has been done in an attempt to allocate the patient to a surgical procedure that outlives them. No questions have been addressed as to whether the extent of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Sørensen, Michala Skovlund, Hindsø, Klaus, Hovgaard, Thea Bechmann, Petersen, Michael Mørk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839836/
https://www.ncbi.nlm.nih.gov/pubmed/27082592
http://dx.doi.org/10.1097/MD.0000000000003354
_version_ 1782428198023200768
author Sørensen, Michala Skovlund
Hindsø, Klaus
Hovgaard, Thea Bechmann
Petersen, Michael Mørk
author_facet Sørensen, Michala Skovlund
Hindsø, Klaus
Hovgaard, Thea Bechmann
Petersen, Michael Mørk
author_sort Sørensen, Michala Skovlund
collection PubMed
description Estimating patient survival has hitherto been the main focus when treating metastatic bone disease (MBD) in the appendicular skeleton. This has been done in an attempt to allocate the patient to a surgical procedure that outlives them. No questions have been addressed as to whether the extent of the surgery and thus the surgical trauma reduces survival in this patient group. We wanted to evaluate if perioperative parameters such as blood loss, extent of bone resection, and duration of surgery were risk factors for 30-day mortality in patients having surgery due to MBD in the appendicular skeleton. We retrospectively identified 270 consecutive patients who underwent joint replacement surgery or intercalary spacing for skeletal metastases in the appendicular skeleton from January 1, 2003 to December 31, 2013. We collected intraoperative (duration of surgery, extent of bone resection, and blood loss), demographic (age, gender, American Society of Anesthesiologist score [ASA score], and Karnofsky score), and disease-specific (primary cancer) variables. An association with 30-day mortality was addressed using univariate and multivariable analyses and calculation of odds ratio (OR). All patients were included in the analysis. ASA score 3 + 4 (OR 4.16 [95% confidence interval, CI, 1.80–10.85], P = 0.002) and Karnofsky performance status below 70 (OR 7.34 [95% CI 3.16–19.20], P < 0.001) were associated with increased 30-day mortality in univariate analysis. This did not change in multivariable analysis. No parameters describing the extent of the surgical trauma were found to be associated with 30-day mortality. The 30-day mortality in patients undergoing surgery for MBD is highly dependent on the general health status of the patients as measured by the ASA score and the Karnofsky performance status. The extent of surgery, measured as duration of surgery, blood loss, and degree of bone resection were not associated with 30-day mortality.
format Online
Article
Text
id pubmed-4839836
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-48398362016-06-02 Extent of Surgery Does Not Influence 30-Day Mortality in Surgery for Metastatic Bone Disease: An Observational Study of a Historical Cohort Sørensen, Michala Skovlund Hindsø, Klaus Hovgaard, Thea Bechmann Petersen, Michael Mørk Medicine (Baltimore) 7100 Estimating patient survival has hitherto been the main focus when treating metastatic bone disease (MBD) in the appendicular skeleton. This has been done in an attempt to allocate the patient to a surgical procedure that outlives them. No questions have been addressed as to whether the extent of the surgery and thus the surgical trauma reduces survival in this patient group. We wanted to evaluate if perioperative parameters such as blood loss, extent of bone resection, and duration of surgery were risk factors for 30-day mortality in patients having surgery due to MBD in the appendicular skeleton. We retrospectively identified 270 consecutive patients who underwent joint replacement surgery or intercalary spacing for skeletal metastases in the appendicular skeleton from January 1, 2003 to December 31, 2013. We collected intraoperative (duration of surgery, extent of bone resection, and blood loss), demographic (age, gender, American Society of Anesthesiologist score [ASA score], and Karnofsky score), and disease-specific (primary cancer) variables. An association with 30-day mortality was addressed using univariate and multivariable analyses and calculation of odds ratio (OR). All patients were included in the analysis. ASA score 3 + 4 (OR 4.16 [95% confidence interval, CI, 1.80–10.85], P = 0.002) and Karnofsky performance status below 70 (OR 7.34 [95% CI 3.16–19.20], P < 0.001) were associated with increased 30-day mortality in univariate analysis. This did not change in multivariable analysis. No parameters describing the extent of the surgical trauma were found to be associated with 30-day mortality. The 30-day mortality in patients undergoing surgery for MBD is highly dependent on the general health status of the patients as measured by the ASA score and the Karnofsky performance status. The extent of surgery, measured as duration of surgery, blood loss, and degree of bone resection were not associated with 30-day mortality. Wolters Kluwer Health 2016-04-18 /pmc/articles/PMC4839836/ /pubmed/27082592 http://dx.doi.org/10.1097/MD.0000000000003354 Text en Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0, where it is permissible to download, share and reproduce the work in any medium, provided it is properly cited. The work cannot be changed in any way or used commercially. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle 7100
Sørensen, Michala Skovlund
Hindsø, Klaus
Hovgaard, Thea Bechmann
Petersen, Michael Mørk
Extent of Surgery Does Not Influence 30-Day Mortality in Surgery for Metastatic Bone Disease: An Observational Study of a Historical Cohort
title Extent of Surgery Does Not Influence 30-Day Mortality in Surgery for Metastatic Bone Disease: An Observational Study of a Historical Cohort
title_full Extent of Surgery Does Not Influence 30-Day Mortality in Surgery for Metastatic Bone Disease: An Observational Study of a Historical Cohort
title_fullStr Extent of Surgery Does Not Influence 30-Day Mortality in Surgery for Metastatic Bone Disease: An Observational Study of a Historical Cohort
title_full_unstemmed Extent of Surgery Does Not Influence 30-Day Mortality in Surgery for Metastatic Bone Disease: An Observational Study of a Historical Cohort
title_short Extent of Surgery Does Not Influence 30-Day Mortality in Surgery for Metastatic Bone Disease: An Observational Study of a Historical Cohort
title_sort extent of surgery does not influence 30-day mortality in surgery for metastatic bone disease: an observational study of a historical cohort
topic 7100
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839836/
https://www.ncbi.nlm.nih.gov/pubmed/27082592
http://dx.doi.org/10.1097/MD.0000000000003354
work_keys_str_mv AT sørensenmichalaskovlund extentofsurgerydoesnotinfluence30daymortalityinsurgeryformetastaticbonediseaseanobservationalstudyofahistoricalcohort
AT hindsøklaus extentofsurgerydoesnotinfluence30daymortalityinsurgeryformetastaticbonediseaseanobservationalstudyofahistoricalcohort
AT hovgaardtheabechmann extentofsurgerydoesnotinfluence30daymortalityinsurgeryformetastaticbonediseaseanobservationalstudyofahistoricalcohort
AT petersenmichaelmørk extentofsurgerydoesnotinfluence30daymortalityinsurgeryformetastaticbonediseaseanobservationalstudyofahistoricalcohort